Genetics and Insurance: What have we Learned So Far?

DOI10.1080/03461230110106426MaRDI QIDQ5467679zbMATH OpenOpenAlexFDO

Authors Angus S. Macdonald

Publication date 24 May 2006

Published in Scandinavian Actuarial Journal (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/03461230110106426

zbMATH Keywords

adverse selectiondiscriminationgenetic epidemiologygeneticsinsuranceunderwriting

Mathematics Subject Classification ID

Recommendations

• The Genetics of Breast and Ovarian Cancer III: A new model of family history with insurance applications
• Effective Underwriting in the Genetic Testing Era
• Genetic Testing, Insurance Economics, and Societal Responsibility
• Restricting Insurers’ Use of Genetic Information
• Premium rates based on genetic studies: How reliable are they?

Cites work

• A Nelson-Aalen Estimate of the Incidence Rates of Early-Onset Alzheimer's Disease Associated with the Presenilin-1 Gene
• Adult Polycystic Kidney Disease and Critical Illness Insurance
• Analysis of multivariate survival data
• Genetics, Alzheimer’s Disease, and Long-Term Care Insurance
• scientific article; zbMATH DE number 1082452 (Why is no real title available?)
• scientific article; zbMATH DE number 3407003 (Why is no real title available?)
• Mathematical and statistical methods for genetic analysis
• Modeling the Impact of Genetics on Insurance
• Pricing Term Insurance in the Presence of a Family History of Breast or Ovarian Cancer
• Statistical models based on counting processes
• The genetics of breast and ovarian cancer. II: A model of critical illness insurance
• The Value of the Aggregate Data Approach in Meta-Analysis with Time-to-Event Outcomes

Cited in

(8)

• The Genetics of Breast and Ovarian Cancer III: A new model of family history with insurance applications
• The Impact of Multifactorial Genetic Disorders on Critical Illness Insurance: A Simulation Study Based on UK Biobank
• Adult polycystic kidney disease and insurance
• Genetics, Alzheimer’s Disease, and Long-Term Care Insurance
• Restricting Insurers’ Use of Genetic Information
• Effective Underwriting in the Genetic Testing Era
• A simulation study for multifactorial genetic disorders to quantify the impact of polygenic risk scores on critical illness insurance
• Premium rates based on genetic studies: How reliable are they?

This page was built for publication: Genetics and Insurance: What have we Learned So Far?

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5467679)